Foresite Capital Opportunity Management V as of Sept. 30, 2022
Portfolio Holdings for Foresite Capital Opportunity Management V
Foresite Capital Opportunity Management V holds 9 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pardes Biosciences | 29.0 | $9.7M | 5.2M | 1.85 | |
| Theseus Pharmaceuticals | 16.7 | $5.6M | 959k | 5.80 | |
| Gemini Therapeutics | 12.0 | $4.0M | 2.4M | 1.64 | |
| Compass Therapeutics (CMPX) | 10.6 | $3.5M | 1.6M | 2.28 | |
| Kinnate Biopharma | 10.5 | $3.5M | 292k | 11.95 | |
| Adicet Bio (ACET) | 7.3 | $2.4M | 170k | 14.22 | |
| Quantum-Si Incorporated Com Cl A (QSI) | 5.2 | $1.7M | 634k | 2.75 | |
| Hims & Hers Health Com Cl A (HIMS) | 5.1 | $1.7M | 306k | 5.58 | |
| Enanta Pharmaceuticals (ENTA) | 3.5 | $1.2M | 23k | 51.87 |
